Columbia Labs (CBRX) Raises Proceeds of $750K Through Sale of Stock to Numoda
More News related to CBRX
- Columbia Laboratories Reports Third Quarter 2009 Financial Results
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
- Columbia Laboratories Closes Registered Direct Common Stock and Warrant Offering
- Columbia Laboratories to Present at the Oppenheimer 20th Annual Healthcare Conference on November 3, 2009
- Unusual 11 Mid-Day Movers 10/23: AMZN, SCSS, ALGN, EPAY Higher; ELN, SNV, CBRX, STSA Lower
Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced that it has raised $750,000 through the sale of 451,807 shares of its common stock at a price of $1.66 per share to Numoda Corporation, which provides improved trial-performance metrics solutions in enrollment, logistics, monitoring and financial efficiencies for life sciences companies. Numoda is currently managing Columbia's ongoing PREGNANT (PROCHIEVE Extending GestatioN A New Therapy) Study of PROCHIEVE(R) 8% (progesterone gel) to reduce the risk of preterm birth in women with a short cervix at mid-pregnancy.
Columbia Laboratories, Inc. engages in the research, development, manufacture, and commercialization of women's healthcare and endocrinology products.
Related Categories
Corporate NewsEquity Offerings
Stocks Mentioned
-0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
